HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haptoglobin. A potential reporter molecule for glycosylation changes in disease.

Abstract
The acute-phase protein, haptoglobin, is elevated in many diseases; however, its glycosylation also changes, and the type of change observed can vary with disease. Increased fucosylation is a common finding, and the fucose-specific lectin, lotus tetragonolobus, can be used to differentiate different diseases (eg inflammatory conditions, liver diseases), and to monitor disease activity in cancer. Changes in N-acetyl neuraminic acid and N-acetylglucosamine suggest that particular carbohydrate structures predominate in certain diseases. Because haptoglobin glycosylation provides a record of previous intracellular events, it will help to improve our understanding of pathological processes and provide potential clinical markers for the future.
AuthorsG A Turner
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 376 Pg. 231-8 ( 1995) ISSN: 0065-2598 [Print] United States
PMID8597253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Haptoglobins
  • Monosaccharides
Topics
  • Acute-Phase Reaction (metabolism)
  • Glycosylation
  • Haptoglobins (chemistry, isolation & purification, metabolism)
  • Humans
  • Inflammation (blood)
  • Monosaccharides (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: